What does breakthrough device designation mean?
FDA Breakthrough Device designation is granted to novel medical devices that have the potential to provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions.
What does breakthrough designation mean for FDA?
Breakthrough Therapy designation is a process designed to expedite the development and review of drugs that are intended to treat a serious condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapy on a clinically significant endpoint(s).
How many breakthrough device designations are there?
657 Breakthrough Device designations
As of March 31, 2022, CDRH and CBER have granted 657 Breakthrough Device designations, including devices originally designated under the Expedited Access Pathway (EAP) program. The following graphs provide the distribution of these designations by fiscal year as well as by clinical panel.
What is the difference between Fastrack and breakthrough designation?
Sponsors should also note the subtle differences in the designation criteria: drugs seeking Fast Track Designation must only have the potential to address an unmet medical need, while drugs seeking Breakthrough Therapy Designation must have preliminary data which demonstrate substantial improvement on clinically …
What makes a device a breakthrough technology under the 21st Century cures act?
To qualify, a device must demonstrate that it provides for more effective treatment or diagnosis of a life-threatening or irreversibly debilitating human disease or condition, and meets one of the following criteria: (1) it represents a breakthrough technology; (2) it has no approved or cleared alternative; (3) it …
What is IDE FDA?
An investigational device exemption (IDE) allows the investigational device to be used in a clinical study in order to collect safety and effectiveness data.
What is a Pdufa from FDA?
The Prescription Drug User Fee Act (PDUFA) was created by Congress in 1992 and authorizes FDA to collect fees from companies that produce certain human drug and biological products. Since the passage of PDUFA, user fees have played an important role in expediting the drug approval process.
What does FDA orphan drug status mean?
Orphan Drug Definition An orphan drug is defined in the 1984 amendments of the U.S. Orphan Drug Act (ODA) as a drug intended to treat a condition affecting fewer than 200,000 persons in the United States, or which will not be profitable within 7 years following approval by the FDA.
What is de novo FDA?
The De Novo request provides a marketing pathway to classify novel medical devices for which general controls alone, or general and special controls, provide reasonable assurance of safety and effectiveness for the intended use, but for which there is no legally marketed predicate device.
What is the second breakthrough treatment?
This is the second Breakthrough Therapy Designation for olorofim; a designation was granted previously on 11 November 2019 for ‘Treatment of invasive mold infections in patients with limited or no treatment options, including aspergillosis refractory orintolerant tocurrently available therapy, and infections due to …
What is an FDA Sprint discussion?
A. These discussions allow for rapid and repeated interactions with FDA about a single topic. Because FDA hopes to engage with breakthrough device designees early and often, the goal of sprint discussions is to reach an agreement in a shorter time frame than would occur by a typical pre-submission process.
What are the contents of IDE?
An IDE typically contains a code editor, a compiler or interpreter, and a debugger, accessed through a single graphical user interface (GUI). The user writes and edits source code in the code editor. The compiler translates the source code into a readable language that is executable for a computer.
What is a breakthrough therapy designation?
If a drug is designated as breakthrough therapy, FDA will expedite the development and review of such drug. All requests for breakthrough therapy designation will be reviewed within 60 days of receipt, and FDA will either grant or deny the request.
What is an FDA breakthrough device designation?
FDA Breakthrough Device designation is granted to novel medical devices that have the potential to provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions.
How long does it take for FDA to respond to breakthrough therapy?
FDA will respond to Breakthrough Therapy designation requests within sixty days of receipt of the request.
What information is included on the drug designation chart?
The chart is updated daily and includes information about each individual agent or trade name of a drug or treatment, the sponsor company, the date of the designation’s public disclosure, the individual agent’s indication, or the broad disease category in which the designation was granted.